tiprankstipranks
Trending News
More News >
Cascades (TSE:CAS)
TSX:CAS

Cascades (CAS) AI Stock Analysis

Compare
217 Followers

Top Page

TSE:CAS

Cascades

(TSX:CAS)

Select Model
Select Model
Select Model
Neutral 53 (OpenAI - 5.2)
Rating:53Neutral
Price Target:
C$12.00
▼(-2.52% Downside)
Action:ReiteratedDate:03/01/26
The score is driven primarily by an improving but still uneven financial profile (profit and free cash flow rebound, but sharp 2025 revenue decline and meaningful leverage). Technical indicators are a key drag (below key moving averages with negative MACD), while valuation and the earnings call provide partial support through a ~4% dividend yield, moderate P/E, solid recent EBITDA momentum, and debt reduction despite cautious near-term demand guidance.
Positive Factors
Revenue Growth
Strong revenue growth indicates robust demand for Cascades' products, enhancing market position and supporting long-term business expansion.
Cash Flow Generation
Improved cash generation enhances financial flexibility, allowing for reinvestment in growth initiatives and debt reduction, supporting long-term stability.
Debt Reduction
Effective debt reduction strengthens the balance sheet, reducing financial risk and interest expenses, which supports sustainable growth.
Negative Factors
High Leverage
High leverage can strain financial resources, limiting flexibility and increasing vulnerability to economic downturns, impacting long-term stability.
Profitability Challenges
Negative profitability indicates challenges in cost management and pricing power, potentially hindering reinvestment and growth opportunities.
Environmental and Restructuring Costs
Significant costs related to environmental and restructuring efforts could pressure margins and limit resources for growth initiatives.

Cascades (CAS) vs. iShares MSCI Canada ETF (EWC)

Cascades Business Overview & Revenue Model

Company DescriptionCascades Inc. produces, converts, and markets packaging and tissue products in Canada and the United States. The company operates through three segments: Containerboard, Specialty Products, and Tissue Papers. It manufactures containerboards, as well as converts corrugated products. The company also offers uncoated recycled paperboards for use in packaging converters and industrial users of headers and wrappers for the paper industry, as well as partitions that are used as protective packaging; honeycomb paperboards for the beer, wine, and spirits industry; laminated paperboards for food packaging and furniture backing industries; and specialty containers, structural components, and paperboard and fiber composites. In addition, it provides egg filler flats and egg cartons for egg processors and four-cup carriers for the quick-service restaurant industry; polystyrene foam trays for processors and retailers in the food industry; rigid plastic packaging products for food industry, processors, and retailers; and flexible films for frozen foods, bakery, and ice industries. Further, the company offers bathroom and facial tissues, paper towels, paper hand towels and napkins, and other related products and services under the Cascades PRO Signature, Cascades PRO Perform, Cascades PRO Select, Cascades PRO Tandem, and Cascades PRO Tuff-Job brands; and under the Cascades Fluff, Cascades Tuff, and Satin Soft labels, as well as private labels and other secondary marks. Additionally, it offers services to recover and process discarded materials for the municipal, industrial, commercial, and institutional sectors. The company sells its products through own sales force and external representatives. Cascades Inc. was incorporated in 1964 and is headquartered in Kingsey Falls, Canada.
How the Company Makes MoneyCascades generates revenue through various key streams, primarily from the sale of its packaging and tissue products. The company produces and sells containerboard and boxboard used in the manufacturing of packaging products, which are distributed to various industries including food, consumer goods, and e-commerce. Additionally, Cascades offers tissue products, including bathroom tissue, paper towels, and napkins, which are sold to both retail and commercial customers. Significant partnerships with major retailers and manufacturers help drive sales while the company's commitment to sustainability attracts environmentally conscious consumers. Furthermore, Cascades benefits from its investments in recycling operations, as these initiatives reduce raw material costs and enhance profitability by providing a consistent supply of recycled fibers for production.

Cascades Earnings Call Summary

Earnings Call Date:Nov 06, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:May 07, 2026
Earnings Call Sentiment Positive
The earnings call indicates a strong performance in Q3 2025, with significant improvements in both the Packaging and Tissue segments, as well as successful debt reduction efforts. However, there are concerns regarding environmental and restructuring costs, along with a cautious outlook for Q4 due to potential demand fluctuations.
Q3-2025 Updates
Positive Updates
Stronger Than Expected Q3 Performance
Cascades' Q3 2025 performance was stronger than projections, driven by improved volumes, higher average selling prices, and lower production costs. Consolidated EBITDA increased by 16% from Q2 and 14% year-over-year.
Packaging Segment Improvement
Packaging sales increased 4% sequentially, with Q3 EBITDA rising 14% sequentially to $136 million. EBITDA margins improved to 17.1% from 15.6% in Q2.
Tissue Business Growth
Third quarter sales in the Tissue segment increased 5% sequentially. EBITDA of $46 million rose 21% from Q2. Year-over-year, sales increased 6% with stronger volumes and higher average selling prices.
Net Debt Reduction
Sequentially, net debt decreased by $81 million in the third quarter, mainly due to stronger cash flow from operations and a reversal in working capital requirements.
Asset Sale and Debt Repayment
Completed sale of Flexible Packaging operation for $31 million, contributing to debt repayment. Total proceeds from asset sales amounted to $57 million this year.
Negative Updates
Environmental and Restructuring Costs
Operating income was impacted by $12 million due to a $10 million environmental provision related to a plant closure in Canada and $6 million of restructuring charges mainly from the Niagara Falls mill closure.
Demand Level Concerns
Cautious outlook for Q4 with anticipated 5% decrease in Packaging volumes due to unusual post-Thanksgiving seasonality and continued macroeconomic uncertainty.
Company Guidance
During the Cascades' Third Quarter 2025 Financial Results Conference Call, the company provided detailed guidance regarding its performance and future expectations. The company reported a consolidated EBITDA of $159 million, which marked a 16% increase from Q2 and a 14% year-over-year increase. Specific to the Packaging segment, Q3 EBITDA increased by 14% sequentially to $136 million, with an improvement in EBITDA margins to 17.1%. The Tissue business also showed strength, with a 21% sequential increase in EBITDA to $46 million. For Q4, Cascades anticipates favorable trends in raw material and selling prices for Packaging, although demand levels are expected to be stable to 10% below Q3 levels due to seasonality and economic uncertainty. The company also highlighted a reduction in net debt by $81 million during Q3, reflecting stronger cash flow from operations, with a leverage ratio decrease to 3.6x. Capital expenditures are projected to be slightly lower than previous estimates for 2025, with expectations set at approximately $140 million. Additionally, Cascades aims to achieve $100 million in run rate profitability improvements by the end of 2026 through ongoing initiatives.

Cascades Financial Statement Overview

Summary
Financials are improving but still mixed: 2025 returned to profitability ($70M net income) and cash generation strengthened (operating cash flow $379M; free cash flow $227M), but revenue fell sharply in 2025 (-29.2%) and earnings have been inconsistent across prior years. Leverage is meaningful (debt-to-equity ~1.13), raising cyclicality risk.
Income Statement
46
Neutral
Revenue has been volatile, with modest growth in 2022–2024 followed by a sharp decline in 2025 (annual revenue growth of -29.2%). Profitability improved meaningfully in 2025 with positive net income ($70M) after losses in 2022–2024, but margins remain thin (about 1.5% net margin in 2025). Operating profitability is positive and improved versus prior years, yet overall earnings power looks inconsistent across the cycle.
Balance Sheet
50
Neutral
Leverage is meaningful with debt running above equity (debt-to-equity ~1.13 in 2025), which reduces flexibility in a downturn. Equity has been relatively stable year-to-year, and returns improved back to positive in 2025 (about 4.1% return on equity), but the business posted negative returns in several prior years. Overall, the balance sheet is serviceable but moderately leveraged for a cyclical packaging business.
Cash Flow
58
Neutral
Cash generation is a relative strength: operating cash flow was solid in 2025 ($379M) and free cash flow improved to $227M, up sharply from 2024. That said, cash flow has been uneven historically (including negative free cash flow in 2021–2022), and 2025 cash conversion was not exceptionally strong relative to accounting earnings (free cash flow running at ~60% of net income). Still, the recent rebound in free cash flow supports debt capacity and reinvestment.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue4.78B4.70B4.64B4.47B3.96B
Gross Profit565.00M1.85B1.66B1.63B491.00M
EBITDA591.00M392.00M330.00M273.00M281.00M
Net Income70.00M-31.00M-76.00M-14.00M-47.00M
Balance Sheet
Total Assets4.67B5.00B4.77B5.05B4.57B
Cash, Cash Equivalents and Short-Term Investments48.00M28.00M54.00M111.00M175.00M
Total Debt1.94B2.12B1.94B2.07B1.52B
Total Liabilities2.92B3.23B2.99B3.13B2.64B
Stockholders Equity1.72B1.72B1.74B1.87B1.88B
Cash Flow
Free Cash Flow227.00M88.00M159.00M-362.00M-90.00M
Operating Cash Flow379.00M272.00M510.00M144.00M211.00M
Investing Cash Flow-94.00M-150.00M-332.00M-486.00M-247.00M
Financing Cash Flow-263.00M-149.00M-225.00M272.00M-529.00M

Cascades Technical Analysis

Technical Analysis Sentiment
Negative
Last Price12.31
Price Trends
50DMA
13.02
Negative
100DMA
12.33
Negative
200DMA
10.77
Positive
Market Momentum
MACD
-0.24
Positive
RSI
34.19
Neutral
STOCH
13.00
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CAS, the sentiment is Negative. The current price of 12.31 is below the 20-day moving average (MA) of 13.23, below the 50-day MA of 13.02, and above the 200-day MA of 10.77, indicating a neutral trend. The MACD of -0.24 indicates Positive momentum. The RSI at 34.19 is Neutral, neither overbought nor oversold. The STOCH value of 13.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CAS.

Cascades Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
C$2.78B14.2210.45%7.11%3.19%-0.26%
73
Outperform
C$15.97B18.8814.88%1.46%7.12%17.15%
70
Neutral
C$1.93B9.658.95%8.22%-2.45%44.20%
65
Neutral
C$89.99M7.4915.15%19.66%-4.69%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
60
Neutral
C$335.96M18.41
53
Neutral
$1.23B18.011.16%3.90%3.50%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CAS
Cascades
12.31
2.07
20.25%
TSE:RIC
Richards Packaging
28.35
0.37
1.30%
TSE:SXP
Supremex
3.69
0.34
10.15%
TSE:TCL.B
Transcontinental Inc. Class B
23.19
7.35
46.38%
TSE:WPK
Winpak
47.31
8.95
23.34%
TSE:CCL.B
CCL Industries
91.73
21.39
30.40%

Cascades Corporate Events

Business Operations and StrategyFinancial Disclosures
Cascades Boosts 2025 Profit, Cuts Debt as Strategic Moves Take Hold
Positive
Feb 26, 2026

Cascades reported fourth-quarter 2025 sales of $1.197 billion, with operating income rising to $76 million and earnings per share improving to $0.37, reflecting stronger packaging performance offset by weaker tissue results and a costly power outage. For full-year 2025, sales grew to $4.776 billion, operating income more than doubled to $235 million, adjusted EBITDA climbed to $576 million, and net debt fell to $1.896 billion, as asset sales surpassed the company’s monetization target and strategic actions began to deliver operational and financial gains.

Management expects first-quarter results to soften sequentially due to normal seasonality, weather-driven cost pressures and lingering impacts from the power outage, though performance should remain above prior-year levels. Looking to 2026, Cascades anticipates results will exceed 2025 as it continues deleveraging, benefits from profitability initiatives and consolidates its positioning in packaging and tissue despite macroeconomic uncertainty.

The most recent analyst rating on (TSE:CAS) stock is a Hold with a C$15.00 price target. To see the full list of analyst forecasts on Cascades stock, see the TSE:CAS Stock Forecast page.

Business Operations and Strategy
Cascades Exits Honeycomb and Partition Packaging to Refocus on Core Markets
Negative
Feb 9, 2026

Cascades Inc. is exiting its honeycomb paperboard and partition packaging segments, closing three plants in Berthierville and Saint-Césaire, Quebec, and York, Pennsylvania, as it concentrates on strategic markets where it sees better long-term growth and profitability. The move underscores a shift away from declining niche markets toward strengthening its core packaging platform, while the adjacent Cascades Sonoco – Berthierville plant remains unaffected.

The Berthierville honeycomb packaging facility shuts immediately, affecting 52 employees, with certain assets sold to Emballages LM for about $9 million to help ensure service continuity for customers. The York plant, with 37 employees, will close by February 19, 2026, and the Saint-Césaire cardboard partition facility, which employs 25 people and has suffered from falling demand and geographic disadvantages, will cease operations by April 17, 2026.

Cascades will provide transition support and job search assistance to affected workers and is encouraging them to seek roles at other company sites. Management frames the closures as a necessary optimization to realign assets with priority sectors and reinforce Cascades’ position as a preferred partner in its chosen packaging markets, signaling a tighter operational focus and potential efficiency gains for stakeholders.

The most recent analyst rating on (TSE:CAS) stock is a Hold with a C$15.00 price target. To see the full list of analyst forecasts on Cascades stock, see the TSE:CAS Stock Forecast page.

Business Operations and StrategyM&A Transactions
Cascades Sells Richmond, B.C. Packaging Plant to Crown Paper Group for $65.5 Million
Positive
Jan 30, 2026

Cascades Inc. has agreed to sell its corrugated packaging plant in Richmond, British Columbia, to Crown Paper Group for $65.5 million, including real estate assets and subject to customary adjustments and closing conditions. The divestiture is part of Cascades’ broader strategy to optimize its operational footprint and reduce debt by reallocating capital to core markets, with management emphasizing that the asset sale monetizes valuable real estate while having no material impact on the packaging segment’s cash flow profile. Because the Richmond facility had limited integration and synergy potential within Cascades’ network due to its geography, the plant is seen as a stronger strategic fit for Crown, whose existing integrated containerboard mill and regional presence in the Pacific Northwest and Western Canada are expected to ensure a seamless transition for employees and customers, reinforce Crown’s regional expansion, and maintain ongoing investment in the site.

The most recent analyst rating on (TSE:CAS) stock is a Buy with a C$16.00 price target. To see the full list of analyst forecasts on Cascades stock, see the TSE:CAS Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 01, 2026